The knockdown of USP7, hnRNPA1 or miR-522 in CAFs observably suppressed tumor growth and enhanced sensitivity to cisplatin (Fig. 7b, c and d), but up-regulated Lipid ROS levels in tumors (Fig. 7e). This evidence concerns the gene USP7 and neoplasm.